These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20187243)

  • 1. Advances in environmental epidemiology.
    Tanner CM
    Mov Disord; 2010; 25 Suppl 1():S58-62. PubMed ID: 20187243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
    Hancock DB; Martin ER; Stajich JM; Jewett R; Stacy MA; Scott BL; Vance JM; Scott WK
    Arch Neurol; 2007 Apr; 64(4):576-80. PubMed ID: 17420321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.
    Abbott RD; Ross GW; White LR; Sanderson WT; Burchfiel CM; Kashon M; Sharp DS; Masaki KH; Curb JD; Petrovitch H
    J Neurol; 2003 Oct; 250 Suppl 3():III30-9. PubMed ID: 14579122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
    Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and etiology of Parkinson's disease: a review of the evidence.
    Wirdefeldt K; Adami HO; Cole P; Trichopoulos D; Mandel J
    Eur J Epidemiol; 2011 Jun; 26 Suppl 1():S1-58. PubMed ID: 21626386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-environment interactions in Parkinson's disease.
    Ross CA; Smith WW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in Parkinson's disease.
    Schapira AH
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S41-3. PubMed ID: 20123556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure.
    Galanaud JP; Elbaz A; Clavel J; Vidal JS; Corrèze JR; Alpérovitch A; Tzourio C
    Mov Disord; 2005 Feb; 20(2):181-9. PubMed ID: 15468111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
    Nuti A; Ceravolo R; Dell'Agnello G; Gambaccini G; Bellini G; Kiferle L; Rossi C; Logi C; Bonuccelli U
    Parkinsonism Relat Disord; 2004 Dec; 10(8):481-5. PubMed ID: 15542008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of animal models of Parkinson's disease for neuroprotective strategies.
    Emborg ME
    J Neurosci Methods; 2004 Oct; 139(2):121-43. PubMed ID: 15488225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family-based case-control study of cigarette smoking and Parkinson disease.
    Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM
    Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
    Powers KM; Kay DM; Factor SA; Zabetian CP; Higgins DS; Samii A; Nutt JG; Griffith A; Leis B; Roberts JW; Martinez ED; Montimurro JS; Checkoway H; Payami H
    Mov Disord; 2008 Jan; 23(1):88-95. PubMed ID: 17987647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Environmental factors in the etiology of Parkinson's disease].
    Zayed J; Ducic S; Campanella G; Panisset JC; André P; Masson H; Roy M
    Can J Neurol Sci; 1990 Aug; 17(3):286-91. PubMed ID: 2207882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
    Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic studies of environmental exposures in Parkinson's disease.
    Elbaz A; Tranchant C
    J Neurol Sci; 2007 Nov; 262(1-2):37-44. PubMed ID: 17673256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.
    Kalda A; Yu L; Oztas E; Chen JF
    J Neurol Sci; 2006 Oct; 248(1-2):9-15. PubMed ID: 16806272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: evidence for environmental risk factors.
    Kieburtz K; Wunderle KB
    Mov Disord; 2013 Jan; 28(1):8-13. PubMed ID: 23097348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cigarette smoking and Parkinson's disease: a population based case-control study].
    Dong JQ; Zhang QH; Jiang ZX; Yi ZY; Yu L; Li ZH; Zhang YQ; Fang MJ; Zhang ZX; Zhang KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):604-7. PubMed ID: 12975019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease.
    Kandinov B; Giladi N; Korczyn AD
    Parkinsonism Relat Disord; 2007 May; 13(4):243-5. PubMed ID: 17275394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinson's disease: Is there a strong environmental contribution?].
    Elbaz A; Moisan F
    Rev Neurol (Paris); 2010 Oct; 166(10):757-63. PubMed ID: 20739042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.